Recent advances in the treatment of non-Hodgkin's lymphomas. Review uri icon

Overview

abstract

  • Non-Hodgkin's lymphomas (NHL) represent a diverse set of diseases, with different treatment pathways based on the stage and type of hematologic cancer. In their presentation at the NCCN 18th Annual Conference, Dr. Jeremy Abramson and Dr. Andrew D. Zelenetz discuss 3 specific B-cell NHLs: follicular lymphoma, mantle cell lymphoma, and chronic lymphocytic leukemia. They provided an overview of the treatment strategies for patients with these hematologic malignancies, and offered highlights from recent clinical trials supporting these recommendations.

publication date

  • May 1, 2013

Research

keywords

  • Lymphoma, Non-Hodgkin

Identity

Scopus Document Identifier

  • 84887501862

Digital Object Identifier (DOI)

  • 10.6004/jnccn.2013.0198

PubMed ID

  • 23704240

Additional Document Info

volume

  • 11

issue

  • 5 Suppl